Beneficial effects of combined therapy with lacidipine and candesartan in obese hypertensive patients
Introduction. Obesity is becoming one of the leading risk factors of coronary heart disease, hypertension, cerebrovascular disease. Despite the presence of a large number of antihypertensive agents and scientific substantiation of antihypertensive treatment principles it would be wrong to assume tha...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2018-12-01
|
Series: | Romanian Journal of Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.2478/rjim-2018-0018 |